Wednesday, October 17, 2018 from 8:30 AM to 5:00 PM EDT
Add to Calendar


Martin Conference Center at Harvard Medical School
77 Avenue Louis Pasteur
Boston, MA 02115

Driving Directions


Susan Megerman
Cancer Center at Beth Israel Deaconess Medical Center

Scientific breakthroughs are revolutionizing cancer care. Targeted therapies and immunotheraies produce durable remissions, but only for some patients, and resistance remains. Will either of these singular approaches cure cancer? Or will a combination rock the world? The initial data is intriguing. Is it compelling?
Vassiliki A. Boussiotis, MD, PhD Beth Israel Deaconess Medical Center
Alan D. D'Andrea, MD Dana-Farber Cancer Institue
Chi Dang, MD, PhD Ludwig Institute/Wistar Institute
Alberto Mantovani, MD Humanitas University of Milan
Paul S. Mischel, MD University of California San Diego
Stefano Piccolo, PhD University of Padua 
Padmanee Sharma, MD, PhD* MD Anderson Cancer Center
Dinah S. Singer, PhD National Institutes of Health
David Solit, MD Memorial Sloan Kettering Cancer Center
Gerburg Wulf, MD, PhD Beth Israel Deaconess Medical Center
*Winner of Pandolfi Award for Women in Cancer Research